BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23131080)

  • 1. Sweet's syndrome with subcutaneous involvement associated with pegfilgrastim treatment: first reported case.
    Llamas-Velasco M; García-Martín P; Sánchez-Pérez J; Fraga J; García-Diez A
    J Cutan Pathol; 2013 Jan; 40(1):46-9. PubMed ID: 23131080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweet's syndrome--like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia.
    Jagdeo J; Campbell R; Long T; Muglia J; Telang G; Robinson-Bostom L
    J Am Acad Dermatol; 2007 Apr; 56(4):690-3. PubMed ID: 17367621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous Sweet's syndrome in congenital neutropenia: association with pegfilgrastim.
    Draper BK; Robbins JB; Stricklin GP
    J Am Acad Dermatol; 2005 May; 52(5):901-5. PubMed ID: 15858487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sweet syndrome following therapeutic use of granulocyte colony stimulating factor].
    Veres K; Haraszti A; Nemes Z; Zeher M
    Orv Hetil; 1999 May; 140(19):1059-61. PubMed ID: 10339998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sweet's syndrome associated with acute myeloid leukemia. Report of one case].
    Molgó N M; de la Sotta F P; Giesen F L; González B S
    Rev Med Chil; 2011 Dec; 139(12):1592-6. PubMed ID: 22446706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sweet's syndrome associated with granulocyte colony-stimulating factor.
    Hasegawa M; Sato S; Nakada M; Nitta H; Shirasaki H; Kasahara K; Takehara K
    Eur J Dermatol; 1998; 8(7):503-5. PubMed ID: 9854164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment.
    Kumar G; Bernstein JM; Waibel JS; Baumann MA
    Am J Hematol; 2004 Jul; 76(3):283-5. PubMed ID: 15224368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sweet's syndrome associated with G-CSF.
    Paydaş S; Sahin B; Seyrek E; Soylu M; Gonlusen G; Acar A; Tuncer I
    Br J Haematol; 1993 Sep; 85(1):191-2. PubMed ID: 7504506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sweet's syndrome in a severely neutropenic patient during therapy with recombinant human granulocyte colony-stimulating factor.
    Chao SC; Lee JY; Tsao CJ
    J Formos Med Assoc; 1997 Apr; 96(4):276-9. PubMed ID: 9136515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute febrile neutrophilic dermatitis (Sweet's syndrome) during therapeutic agranulocytosis in acute myeloblastic leukemia].
    Torri O; Ruto F; Dierick A; Labeille B; Lok C; Desablens B; Denoeux JP
    Ann Dermatol Venereol; 1993; 120(12):884-8. PubMed ID: 8074347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweet's syndrome masquerading as facial cellulitis.
    Crum NF; Higginbottom PA; Fehl FC; Graham BS
    Cutis; 2003 Jun; 71(6):469-72. PubMed ID: 12839258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor.
    Uhara H; Saida T; Nakazawa H; Ito T
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S10-2. PubMed ID: 18625369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histiocytoid neutrophilic dermatoses and panniculitides: variations on a theme.
    Chow S; Pasternak S; Green P; Tremaine R; Reardon M; Murray S; Northgrave S; Walsh N
    Am J Dermatopathol; 2007 Aug; 29(4):334-41. PubMed ID: 17667165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report].
    Nelis S; Azerad MA; Drowart A; Lewalle P; Efira A
    Rev Med Interne; 2019 Apr; 40(4):258-261. PubMed ID: 30551891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous Sweet's syndrome after granulocyte colony-stimulating factor therapy in a child with congenital neutropenia.
    Akilov OE; Desai N; Jaffe R; Gehris RP
    Pediatr Dermatol; 2014; 31(2):e61-2. PubMed ID: 24387761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies and agranulocytosis together with granulocyte colony-stimulating factor induced Sweet's syndrome in a patient with Graves' disease.
    Ozlem C; Deram B; Mustafa S; Koray T; Cuyan D; Ertugrul T
    Intern Med; 2011; 50(18):1973-6. PubMed ID: 21921379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute neutrophilic myositis in Sweet's syndrome: late phase transformation into fibrosing myositis and panniculitis.
    Attias D; Laor R; Zuckermann E; Naschitz JE; Luria M; Misselevitch I; Boss JH
    Hum Pathol; 1995 Jun; 26(6):687-90. PubMed ID: 7774902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Particular histological features of a case of Sweet's syndrome induced by G-CSF].
    Abecassis S; Ingen-Housz-Oro S; Cavelier-Balloy B; Arnulf B; Bachelez H; Dubertret L
    Ann Dermatol Venereol; 2004 Apr; 131(4):369-72. PubMed ID: 15258512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia.
    Fukutoku M; Shimizu S; Ogawa Y; Takeshita S; Masaki Y; Arai T; Hirose Y; Sugai S; Konda S; Takiguchi T
    Br J Haematol; 1994 Mar; 86(3):645-8. PubMed ID: 7519039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature.
    Chan MP; Duncan LM; Nazarian RM
    J Am Acad Dermatol; 2013 Jun; 68(6):1006-15. PubMed ID: 23399459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.